Reason for request
Inclusion on the list of medicines refundable by National Health Insurance and approved for hospital use.
Clinical Benefit
| Low |
The actual benefit of BRONCHITOL is low. |
Clinical Added Value
| no clinical added value |
BRONCHITOL does not offer any improvement in actual benefit (IAB V) in the management of adult patients aged 18 and over with cystic fibrosis. |
eNq1mFFv2jAQx9/5FFHeSQi0K50C1cbaDanVGC3atJfKJEcxc+30bAPdp59D6EYnR20Nfozt/O/i+/vnU9Kz9T0LloCSCt4Lk6gVBsAzkVN+1wsnNxfNbnjWb6QLsiQ7y06iVpS0wyBjRMpeWM5GUyBcRj+uLj+BeR8w7DeCVEwXkKln67SiLPpC5PyKFOWaIF0Kmgf3oOYi74WFVpvRIJUKTRb9lcBfsiAZpPF2ZHd2cXu0O57GpdgrVLUEvCT8zioK3Ekz04jA1YAouBP4WJNvx0mbyjFIoTGDEVHzEYolzSG3hpgRJsEpyGyVXwMuGagyiFU8XmT30kmcLMh6DA9De9IfzOxArVWz1UxOuq2kc9RttbudrlMo3NkqexXMR8TZbdJJTtuddgw8nqLg2ZwqwRzLMxKoCPNUGCoHz73lKQ7Cw4sGyKksGHmMFrJw3SqCxEwDGgL4+5DyC27QMImZPftPn2vG4jdmPdkSw1PGJZAGQnNVA46LsetGDARXsK6vqBvr1HrrRQrycLK/BbdzfqSnjGauVDPc0SDVZDysh9qBefCRSJigPyB8pzwXK3l40OwW1lP2xYaVVtEC8+S2fdp9lxwfO5+jn8ZFNffMuUZRQGwQROU+ZBnymdiXKcaYdqknWx7SkZuGR2SEQU3L03QkjLHiU4fmzez+DlI1YRX9fH7j6pBvGvDxevNolaZ5729t3fDrg+nGj7WJv93d1SH30gxrtMNjrlQh38fxnMimJGaHohn6YPvOjeqvE/dybVdtTMVHT6lPq4vv9QVyPWQvXer7Nqrb97cNsTWGQg171KHisTdqDs8PD+J/Xaq3tEfPwOEvzKajJIoK7qvN0VOr4n7oN3XlF4Zg6utsRmv+itT6Mo2rPzL9RhqXf2P6jT+Xq+Zz
0nLyaMcW4C7CX8zb
